Oragenics Inc Market Cap ($2.42 Million)
Market Cap & Net Worth: Oragenics Inc (OGEN)
Oragenics Inc market cap. Oragenics Inc (NYSE MKT:OGEN) has a market capitalization of $2.42 Million ($2.42 Million) as of November 1, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #29821 globally and #6094 in its home market, demonstrating a 5.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oragenics Inc's stock price $0.60 by its total outstanding shares 4336029 (4.34 Million). Also see OGEN operating cash flow for how efficiently the company converts equity into cash flow.
Oragenics Inc Market Cap History (2015–2026)
Oragenics Inc market cap history from 2015 to 2026. Data shows change from $3.90 Billion to $2.60 Million (-49.55% CAGR). Check OGEN stock price and chart for real-time trading data and today's change.
Oragenics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oragenics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Oragenics Inc equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
647.91x
Oragenics Inc's market cap is 647.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $116.03 Million | $86.99K | -$15.71 Million | 1333.90x | N/A |
| 2022 | $27.34 Million | $131.52K | -$14.29 Million | 207.90x | N/A |
| 2023 | $24.40 Million | $37.65K | -$20.66 Million | 647.91x | N/A |
Competitor Companies of OGEN by Market Capitalization
Companies near Oragenics Inc in the global market cap rankings as of November 1, 2026. Also see OGEN current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Oragenics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Oragenics Inc (2015–2026)
Market capitalization of Oragenics Inc from 2015 to today. Between 2015 and today, Oragenics Inc's market cap moved from $3.90 Billion to $ 2.60 Million, with a yearly change of -49.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.60 Million | -23.08% |
| 2025 | $3.38 Million | +111.21% |
| 2024 | $1.60 Million | -93.44% |
| 2023 | $24.40 Million | -10.78% |
| 2022 | $27.34 Million | -76.43% |
| 2021 | $116.03 Million | -0.67% |
| 2020 | $116.81 Million | -14.15% |
| 2019 | $136.06 Million | -39.10% |
| 2018 | $223.43 Million | -63.44% |
| 2017 | $611.12 Million | -56.50% |
| 2016 | $1.40 Billion | -64.00% |
| 2015 | $3.90 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Oragenics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.42 Million USD |
| MoneyControl | $2.42 Million USD |
| MarketWatch | $2.42 Million USD |
| marketcap.company | $2.42 Million USD |
| Reuters | $2.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oragenics Inc
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation w… Read more